Back - Takaisin

Next - Seuraava

Previous - Edellinen

Print - Tulosta

	Comment to: - Komentti viestiin: Levtr
	I love the theatre http://efukt.fun/ efukt.com Boehringer Ingelheim has officially entered the oncology space. The FDA approved the private company's once-daily pill for metastatic non-small cell lung cancer (NSCLC) medication, Gilotrif, on Friday. The FDA gave the first-line oral cancer treatment orphan drug status and priority review. , Author: - Kirjoittanut: Anonymous, 07/20/2019,
	Message: - Viesti:
	I love the theatre http://efukt.fun/ efukt.com Boehringer Ingelheim has officially entered the oncology space. The FDA approved the private company's once-daily pill for metastatic non-small cell lung cancer (NSCLC) medication, Gilotrif, on Friday. The FDA gave the first-line oral cancer treatment orphan drug status and priority review.